Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation Miami Valves 2024

Testing the Limits of TEER Beyond COAPT

Presenter: Diego H. González-Bravo

February 03, 2024

Presentation Miami Valves 2024

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Presenter: Solomon A. Seifu

February 03, 2024

Presentation ACC 2023

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Presenter: Gregg W. Stone

March 05, 2023

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

Presenter: Bahira Shahim

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

Presentation TVT 2020

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

Presenter: Gennaro Giustino

June 21, 2020

Presentation AVIC 2020

MITRA-FR and COAPT : What Do We Know Now ?

Presenter: Alec Vahanian

January 31, 2020

Presentation CACI 2019

COAPT Three-Year Outcomes from a Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients with Heart Failure and Secondary Mitral Regurgitation

Presenter: Oscar A. Mendiz

November 29, 2019

Presentation EuroPCR 2019

The Mitral Valve Repair Clinical (MAVERIC) trial

Presenter: Simon Redwood

May 21, 2019

Presentation EuroPCR 2019

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

Presenter: Saibal Kar

May 21, 2019

Presentation ARCH 2019

The Take Home Message of COAPT

Presenter: David G. Rizik

April 12, 2019

Presentation SIF 2019

The Take Home Message of COAPT

Presenter: David G. Rizik

March 27, 2019

Presentation ACC 2019

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Presenter: Suzanne V. Arnold

March 18, 2019

Presentation ACC 2019

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Presenter: Federico M. Asch

March 17, 2019

Presentation JIM 2019

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Presenter: Gregg W. Stone

February 14, 2019

Presentation JIM 2019

Impact of COAPT on the Future of TMVR

Presenter: Martin B. Leon

February 14, 2019

Advertisement

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Testing the Limits of TEER Beyond COAPT

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Functional Status and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure and Secondary MR: The COAPT Trial

MITRA-FR and COAPT : What Do We Know Now ?

COAPT Three-Year Outcomes from a Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients with Heart Failure and Secondary Mitral Regurgitation

The Mitral Valve Repair Clinical (MAVERIC) trial

Relationship Between Residual Mitral Regurgitation and Clinical and Functional Outcomes in the COAPT Trial

The Take Home Message of COAPT

The Take Home Message of COAPT

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Treatment of Mitral Regurgitation in Heart Failure COAPT and beyond

Impact of COAPT on the Future of TMVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content